On Monday 16 February, the European Commission decided to close its antitrust investigation into alleged anti-competitive behaviour by Edwards Lifesciences, a US manufacturer of medical devices for cardiovascular applications.
The closure of the investigation follows the company’s withdrawal of its Global Unilateral Pro-Innovation (Anti-Copycatting) Policy (UPIP). This policy is therefore no longer applicable and has been removed from the company’s website.
In September 2023, the...